Biotechnology Market Research Reports & Industry Analysis

... significant regulatory progress has been made in recent years, clarity is distinctly lacking on certain issues, such as interchangeability and naming.  FirstWord’s Biosimilars: Regulatory Outlook provides insight and opinion on why. This 64 page report gives in-depth and candid views on what eight industry and biosimilar experts ...

... that it has published a new study Biometrics: Market Shares, Strategy, and Forecasts, Worldwide, 2015 to 2021. Next generation biometrics implements smart devices that leverage better ... biometrics market is $7.0 billion in 2014, rising to $44.2 billion by 2021. Biometrics revenue and device shipment forecasts are segmented by modality and market segment. There are four market ...

... research report, “Opportunities in Indian Stem Cell Market”, India has the potential to become one of the fastest growing stem cell markets in the world, mainly owing to Stem Cell Banking segment ... authored to evaluate the Indian Stem Cell Market in terms of Stem Cell Banking and Stem Cell Research, so as to identify the market potential and future growth opportunities. It provides extensive research ...

... of Chinese stem cells medicine industry; To analyze major rivals of stem cells medicine in China; To disclose market size of China’s stem cells medicine industry; To discuss influence of governmental regulation on stem cells medicine ... demands of stem cells medicine; To understand position of China’s stem cells medicine in the world; To predict what future of China’s stem cells medicine industry will be; To reveal opportunities in Chinese stem cells medicine ...

... . Aruvian Research analyzes the Global Biotechnology Industry in this comprehensive research report. Analyzing the Global Biotechnology Industry covers the ... . An industry definition precedes this section. The Global Biotechnology Industry is analyzed through Porter's Five Forces Strategy Analysis. We look ...

... these can be met with innovations from the bio-electronics industry. Capability & Market Analysis Currently Europe is making a huge impact in the ... biomedicine and semiconductors in the country. Currently, biomedical and life sciences applications have the largest market share among applications followed by ...

... report, ASKCI will introduction to market situation of biotechnology industry in global, as well as analyzes the major biotechnology listed company in the globe, including business structure, operation ...

... income in China. Global and China Biomedicine Market 2012-2020: Market Size, Structure, Trends, Analysis and Forecast reviews the worldwide market of biological medicines and reagents with Chinese biomedicine market examined in detail ...

... growth of the market. The growth of market lies in Future E-commerce and emerging mobile trends. Security of Biometric Data is the biggest challenge for Next Generation Biometrics market. Global Next Generation Biometrics market is segmented by Authentication Type, by Function, by Application and by Geography. Based on Authentication Type, market is segmented into ...

... , through 2021. Global market for biologics by drug class, through 2021. Global market for biosimilars by region, through 2021. Global market for biosimilars by indication, through 2021. Global market for biosimilars by drug ...

2015 Global Biomarkers Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Biomarkers industry, focusing on the main regions ... with: 1.) basic information; 2.) the Asia Biomarkers industry; 3.) the North American Biomarkers industry; 4.) the European Biomarkers industry; 5.) market entry and investment feasibility; and ...

2015 Global Biosimilars Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Biosimilars industry, focusing on the main regions ... with: 1.) basic information; 2.) the Asia Biosimilars industry; 3.) the North American Biosimilars industry; 4.) the European Biosimilars industry; 5.) market entry and investment feasibility; and ...

Filgrastim & Pegfilgrastim Biosimilars & Biosuperiors 2015 – a G-CSF & GM-CSF Competitor Analysis The Competitive Intelligence report Filgrastim & Pegfilgrastim Biosimilars & Biosuperiors 2015 – a G-CSF & GM-CSF Competitor Analysis describes product ... G-CSF products represent an attractive market size for biosimilar proteins in regulated markets. Biosimilar filgrastim products have already been introduced into the the ...

... Stem Cell Therapies Clinical Pipeline by Company, Indication & Phase Global Stem Cell Therapies in Clinical Pipeline: 114 Therapies Majority Stem Cell Therapies in Preclinical Phase: 38 Therapies Marketed Stem Cell Therapies Clinical Insight by Brand Name, Company & Indication Marketed Stem Cell Therapies ...

... market will at some point provide a secondary benchmark for biosimilar developers, physicians, patients and payers, when data from a much anticipated 500-patient switching study ... in the EU5 the following questions this week… Has your view towards current/future usage of biosimilar TNF inhibitors become more ...

... NIFTY tests are also looking to capture maximum pie of the Global NIPT market. Global - Non-Invasive Prenatal Testing (NIPT) Volume Analysis: In the Global NIPT Test Volume, NIFTY Test captured ... “Global - Non-Invasive Prenatal Testing (NIPT) Market and Volume Analysis to 2020” is a 107 page report with 40 Figures and 13 Table. This report analyses the Global - Non-Invasive Prenatal Testing (NIPT ...

... following pointers: Market Penetration: Comprehensive information on the product portfolios of the top players in the immunoassay market. The report analyzes the immunoassay market by technology, products and services, applications, end user, and region Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities ...

... latest Chinese guidance for development, evaluation, license approval of biosimilars, Latest Chinese Guidance for Development, Evaluation, License Approval of Biosimilars provided a comprehensive and thorough knowledge of the latest Chinese guidance for development, evaluation, license approval of biosimilars ...

... and effectiveness of medical implants and its associated procedures. This has contributed considerably to the growth of the biomaterials market. The global implantable biomaterials market is segmented on materials types, applications and region. Depending on the materials type the market is segmented into four ...

The North American biostimulants market is estimated to grow at a CAGR of 14.1% from 2014 to 2019. The North America market is leading the global biostimulants market. Globally, North America is one of the most technically advanced ... in the North American biostimulants market Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various application of biostimulants across North America Market Diversification: Exhaustive ...

... benefits associated with orthobiologics products are propelling the growth of orthobiologics market. The companies operating in this market have been stressing on new product developments, and mergers ... in the orthobiologics market Product/ Brand Perception Analysis: Comprehensive study of customer perception and behavior through our inbuilt social connect tools (digital marketing language ...

... bioinformatics market by sectors, products and services, application and geography. Knowledge management tools accounted for the largest share of the global bioinformatics market ...

... physician sentiment to the CMS guidance. In our first poll, focused on Part B reimbursement, we are asking oncologists… How effective they expect the CMS reimbursement guidance to be in incentivising physicians ... of 'de-facto' interchangeability via CMS guidance Their view on interchangeability status for ...

Competitor Analysis: The rapeutic Antibodies 2015: Biosimilars & Biosuperiors This Competitive Intelligence Report about The rapeutic Antibodies 2015: Biosimilars & Biosuperiors provides a competitor ...

Competitor Analysis: EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux This Competitive Intelligence Report about EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux provides a competitor evaluation in the field of recombinant antibodies targeting epithelial growth factor receptor (EGF-R) to treat solid tumors as of March 2015 ...

Competitor Analysis: CD20 Antibodies 2015 - Biosimilars and Biosuperiors of Rituximab This Competitive Intelligence Report about CD20 Antibodies 2015- Biosimilars and Biosuperiors of Rituximab provides a competitor evaluation in the field of recombinant antibodies targeting CD20 for treatment of B-cell mediated ...

Competitor Analysis: TNF Antibodies 2015– Biosimilars and Biosuperiors of Humira, Remicade and Enbrel The present Competitive Intelligence report about TNF Antibodies 2015– Biosimilars and Biosuperiors of Humira, Remicade and Enbrel provides a competitor evaluation in the field of recombinant antibodies targeting tumor necrosis factor (TNF) alpha ...

... for. FirstWord polled US-based oncologists on this issue, among others, following the ODAC meeting in January (see Physician Views Poll Results: Positive FDA sentiment for biosimilar Neupogen shared by oncologists). While Zarxio is a trailblazer in the ...

... Antibodies Global Monoclonal Antibodies Market Overview Global Monoclonal Antibodies Clinical Pipeline by Company, Indication & Phase Global Monoclonal Antibodies Clinical Pipeline: 1096 mAb Marketed Monoclonal Antibodies: 66 mAb Global Cancer Monoclonal Antibodies Clinical Pipeline: 602 mAb Marketed Cancer ...

Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin This Competitive Intelligence Report about Her2 Antibodies 2015 - Biosimilars and ... and make out about 81% of the franchise sale. Therefore, the Her2 antibody market is not only highly attractive for biosimilar developments ...

... biocatalysts market is anticipated to show a high growth rate in the coming years. The market is innovation driven and investments are expected for new biocatalysis process ... in future years. Advancement in biocatalysis process along with increasing penetration of biocatalysts in different applications is driving the growth of the global biocatalysts market. Novozymes (Denmark), DuPont ...

Competitor Analysis: VEGF & VEGF-R Antibodies 2015 – Biosimilars and Biosuperiors of Avastin and Lucentis This Competitive Intelligence Report about VEGF and VEGF-R ... more cancer and eye disease indications. The commercial success of the VEGF antibodies and the expiry of patent protection has laid the ground ...

... stimulants in turf & ornamentals market in 2013. Furthermore, the agricultural bio stimulants in turf & ornamentals market in Latin America is expected to grow at a CAGR of 15.6% from 2014 to 2019, followed by the market in North ... in turf & ornamentals market Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various agricultural bio stimulants in turf & ornamentals across geographies Market Diversification ...

... report is an in-depth financial evaluation of the Nordic Biotechnology. Using the unique Plimsoll method of analysis, each of the largest 250 companies is individually assessed ... are some of the key findings of this new report: 60 of the 250 companies analysed have been rated as Danger 45 companies are ripe ...

... depth financial evaluation of the Global Biotechnology (Pharmaceuticals). Using the unique Plimsoll method of analysis, each of the largest 390 companies is individually assessed ... are some of the key findings of this new report: 197 of the 390 companies analysed have been rated as Danger 167 companies are ...

... , Spain and Italy, Medical Affairs Reputations (EU5): Biosimilar mAbs in Inflammatory Disorders offers insights on how Medical Affairs teams from companies developing and marketing biosimilar anti-TNF monoclonal ... , Spain, the UK; EU5 – biosimilar mAb developers and companies marketing branded mAbs require solid evidence upon which to base medical affairs’ strategy for their ...

All biotech companies - Gilead (GILD), Amgen (AMGN), Biogen Idec (BIIB) and Celgene (CELG), in past year, have given a positive return and hence increased the interest of biotech investors. These companies have been ...

... players (Daiichi-Sankyo, KHK), JP Innovator+ GE companies (Meiji, Fujifilm, Nippon Kayaku, Mochida, and Kissei), Global Multinationals (Pfizer, Sandoz) and some rising star JP local companies (Yoshindo, Gene Techno Science, Sanwa Kagaku ...

... with aging (dementia, Alzheimer's etc.) are on the rise!. Consequently the pharma industry continues to grow and is projected ... the way diseases are treated is the Stem cell therapy/Regenerative Medicine space. The number of companies and products in the clinic have reached a critical mass warranting a ...

This report analyzes the worldwide markets for Biopreservation in US$ Million. The Global market is further analyzed by the following Product Segments, Applications, and Biospecimen ... forecasts are provided for the period 2013 through 2020. Market data and analytics are derived from primary and secondary ...

This report analyzes the worldwide markets for Biosimulation Technology in US$ Thousand. The report provides separate comprehensive analytics for the US, ... forecasts are provided for the period 2013 through 2020. Market data and analytics are derived from primary and secondary ...

... prices dropping and reliability and convenience going up, the promise offered by biometrics to the world in the diverse ways of managing identities is beyond comprehension ... , Surveillance and Others. The report also analyzes the global Biometrics market for prominent end-use sectors including Government & Civil ...

This report analyzes the worldwide markets for Biophotonics in US$ Million by the following End-Use Sectors: Medical (Therapeutics, Diagnostics, & ... 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

This report analyzes the worldwide markets for Fingerprint Biometrics in US$ Million by the following Product Segments: Automated FIS, and Non- ... , Inc. Cross Match Technologies, Inc. DERMALOG Identification Systems GmbH Fingerprint Cards AB

... report analyzes the worldwide markets for Marine Biotechnology in US$ Million. The Global market is further analyzed by the following Product Segments: Marine Biomaterials, Marine Bioactive Substances, and Others. The Major End-Use Applications analyzed are Industrial Products, Health Care/Biotechnology, Consumer ...

... stem cells, namely the segments for stem cell bone grafts and concentrated bone marrow. The products within these markets offer the greatest regenerative potential for healing bone. Orthopedic biomaterial ...

... “Global Biosimilar Market: Trends & Opportunities (2015 Edition)” analyzes the global biologics market, with exhaustive discussion on demand of Biosimilars with increase in patent expiry of innovator drugs. The key market ... titled “The Global Biosimilar Market: Trends & Opportunities (2014-2018)” provides an in-depth analysis of the growing Biosimilar Market with detailed analysis of market sizing and growth, market share and ...

The report provides in-depth information on technologicial platforms being developed for monoclonal antibodies and how they have been improvised for biosimilar development. Also various issues pertaining to manufacturing of biosimilars have been highlighted with possible solutions to to address the hurdles.

... bio-based materials and to make short-term prediction. The above hot topics in China’s bio-based materials market will be explored and reported by CCM in detail in this e-journal, Bio-based Materials China News 1412 ...

This data report provides key statistics and concise analysis on biopharmaceuticals mfg. industry in China. It presents an overview on biopharmaceuticals mfg. industry's overall performance for the year 2011 to 2013, and reveals differences in various regions of Mainland China in terms of biopharmaceuticals ...